Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
0.9786
-0.0164 (-1.65%)
At close: May 18, 2026, 4:00 PM EDT
0.9849
+0.0063 (0.64%)
After-hours: May 18, 2026, 7:54 PM EDT
Nuwellis Revenue
Nuwellis had revenue of $2.40M in the quarter ending March 31, 2026, with 26.21% growth. This brings the company's revenue in the last twelve months to $8.77M, down -0.20% year-over-year. In the year 2025, Nuwellis had annual revenue of $8.27M, down -5.38%.
Revenue (ttm)
$8.77M
Revenue Growth
-0.20%
P/S Ratio
0.29
Revenue / Employee
$230,763
Employees
38
Market Cap
2.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.27M | -470.00K | -5.38% |
| Dec 31, 2024 | 8.74M | -124.00K | -1.40% |
| Dec 31, 2023 | 8.86M | 321.00K | 3.76% |
| Dec 31, 2022 | 8.54M | 622.00K | 7.85% |
| Dec 31, 2021 | 7.92M | 480.00K | 6.45% |
| Dec 31, 2020 | 7.44M | 1.93M | 35.02% |
| Dec 31, 2019 | 5.51M | 513.00K | 10.26% |
| Dec 31, 2018 | 5.00M | 1.45M | 40.67% |
| Dec 31, 2017 | 3.55M | 2.26M | 175.64% |
| Dec 31, 2016 | 1.29M | 1.23M | 2,084.75% |
| Dec 31, 2015 | 59.00K | -236.00K | -80.00% |
| Dec 31, 2014 | 295.00K | 236.00K | 400.00% |
| Dec 31, 2013 | 59.00K | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | 407.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| ENvue Medical | 2.55M |
| Catheter Precision | 819.00K |
| Co-Diagnostics | 718.17K |
| iTonic Holdings | 523.03K |
| Profusa | 75.00K |
| HeartSciences | 8.67K |
NUWE News
- 4 days ago - Nuwellis completes Aquadex SmartFlow System pre-submission meeting with the FDA - TheFly
- 4 days ago - Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label - GlobeNewsWire
- 6 days ago - Nuwellis Earnings Call Transcript: Q1 2026 - Transcripts
- 6 days ago - Nuwellis, Inc. Announces First Quarter 2026 Financial Results - GlobeNewsWire
- 13 days ago - Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026 - GlobeNewsWire
- 19 days ago - Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting - GlobeNewsWire
- 20 days ago - Nuwellis gets notice of allowance from USPTO for lumen midline catheter - TheFly
- 20 days ago - Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology - GlobeNewsWire